Insufficient measles antibody protection in 6-month-old Malawian infants: Reconsider vaccination schedule?
Malawi
infants
maternal protection
measles
vaccination schedule
Journal
Tropical medicine & international health : TM & IH
ISSN: 1365-3156
Titre abrégé: Trop Med Int Health
Pays: England
ID NLM: 9610576
Informations de publication
Date de publication:
09 2023
09 2023
Historique:
medline:
8
9
2023
pubmed:
3
8
2023
entrez:
2
8
2023
Statut:
ppublish
Résumé
Measles vaccination is currently recommended at 9 months, since maternal antibodies are supposed to protect infants until that age. In this study of 6-month-old Malawian infants 98.3% (58/59) had non-protective IgG levels against measles, irrespective of HIV exposure. Anticipating the first dose at 6 months could be considered.
Substances chimiques
Antibodies, Viral
0
Measles Vaccine
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
731-735Informations de copyright
© 2023 John Wiley & Sons Ltd.
Références
WHO. Measles deaths increased by 50% globally between 2016 and 2019, reaching 207,500 deaths in 2019. Available from: https://www.who.int/fr/news/item/12-11-2020-worldwide-measles-deaths-climb-50-from-2016-to-2019-claiming-over-207-500-lives-in-2019. Accessed 13 Jan 2023.
Flannery DD, Zevallos Barboza A, Wade KC, Pfeifer MR, Gerber JS, Morris JS, et al. Measles serostatus among parturient patients at 2 Philadelphia hospitals in 2021. Jama. 2023;329:682-684. https://doi.org/10.1001/jama.2023.0166
EPI Comprehensive Multi-Year Plan 2016-2020 Malawi 2018. Available from: https://extranet.who.int/countryplanningcycles/sites/default/files/planning_cycle_repository/malawi/malawi_cmyp_2016-2020.pdf. Accessed 5 Feb 2023.
Minetti A, Kagoli M, Katsulukuta A, Huerga H, Featherstone A, Chiotcha H, et al. Lessons and challenges for measles control from unexpected large outbreak. Malawi Emerg Infect Dis. 2013;19:202-209. https://doi.org/10.3201/eid1902.120301
Kainga HW, Ssendagire S, Ssanyu JN, Nabukeera S, Namuhani N, Mangen FW. Proportion of children aged 9-59 months reached by the 2017 measles supplementary immunization activity among the children with or without history of measles vaccination in Lilongwe district, Malawi. PLoS One. 2021;16:e0243137. https://doi.org/10.1371/journal.pone.0243137
Malawi: WHO and UNICEF estimates of immunization coverage: 2021 revision. Available from: https://data.unicef.org/resources/immunization-country-profiles/. Accessed 5 Feb 2023.
Kundrick A, Huang Z, Carran S, Kagoli M, Grais RF, Hurtado N, et al. Sub-national variation in measles vaccine coverage and outbreak risk: a case study from a 2010 outbreak in Malawi. BMC Public Health. 2018;18:741. https://doi.org/10.1186/s12889-018-5628-x
Ntenda PAM, Nkoka O, Nana AW, Majoni P, Mhone TG, Tinashe Tizifa T, et al. Factors associated with completion of childhood immunization in Malawi: a multilevel analysis of the 2015-16 Malawi demographic and health survey. Trans R Soc Trop Med Hyg. 2019;113:534-554. https://doi.org/10.1093/trstmh/trz029
Waaijenborg S, Hahné SJ, Mollema L, Smits GP, Berbers GA, van der Klis FR, et al. Waning of maternal antibodies against measles, mumps, rubella, and varicella in communities with contrasting vaccination coverage. J Infect Dis. 2013;208:10-16. https://doi.org/10.1093/infdis/jit143
Manirakiza A, Kipela JM, Sosler S, Daba RM, Gouandjika-Vasilache I. Seroprevalence of measles and natural rubella antibodies among children in Bangui, Central African Republic. BMC Public Health. 2011;11:327. https://doi.org/10.1186/1471-2458-11-327
Baba U, Ashir G, Mava Y, Elechi H, Saidu G, Kaleb A. Transplacental transfer of macromolecules: proving the efficiency of placental transfer of maternal measles antibodies in mother: infant pairs. Ann Med Health Sci Res. 2014;4:S298-S301. https://doi.org/10.4103/2141-9248.141975
Abu-Raya B, Kollmann TR, Marchant A, MacGillivray DM. The immune system of HIV-exposed uninfected infants. Front Immunol. 2016;7:383. https://doi.org/10.3389/fimmu.2016.00383
Slogrove AL, Powis KM, Johnson LF, Stover J, Mahy M. Estimates of the global population of children who are HIV-exposed and uninfected, 2000-18: a modelling study. Lancet Glob Health. 2020;8:e6775. https://doi.org/10.1016/S2214-109X(19)30448-6
WHO. Vaccination schedule for Measles. 2019. Available from: https://immunizationdata.who.int/pages/incidence/MEASLES.html?CODE=MWI&YEAR=. Accessed 12 Feb 2023.
Aaby P, Martins CL, Garly ML, Rodrigues A, Benn CS, Whittle H. The optimal age of measles immunisation in low-income countries: a secondary analysis of the assumptions underlying the current policy. BMJ Open. 2012;2:e000761. https://doi.org/10.1136/bmjopen-2011-000761
Pollard AJ, Finn A, Curtis N. Non-specific effects of vaccines: plausible and potentially important, but implications uncertain. Arch Dis Child. 2017;102:1077-1081.
Mutsaerts EAML, Nunes MC, Bhikha S, Ikulinda BT, Boyce W, Jose L, et al. Immunogenicity and safety of an early measles vaccination schedule at 6 and 12 months of age in human immunodeficiency virus (HIV)-unexposed and HIV-exposed, uninfected South African children. J Infect Dis. 2019;220:1529-1538. https://doi.org/10.1093/infdis/jiz348
UNAIDS Country factsheets: Malawi 2021. Available from: https://www.unaids.org/en/regionscountries/countries/malawi. Accessed 3 Mar 2023.
Ciccacci F, Tolno VT, Doro Altan AM, Liotta G, Orlando S, Mancinelli S, et al. Non communicable diseases burden and risk factors in a cohort of HIV+ elderly patients in Malawi. AIDS Res Hum Retroviruses. 2019;35:1106-1111. https://doi.org/10.1089/AID.2019.0125
Floridia M, Orlando S, Andreotti M, Mphwere R, Kavalo T, Ciccacci F, et al. A 12-month prospective study of HIV-infected and HIV-uninfected women and their infants in Malawi: comparative analysis of clinical events and infant growth. Am J Trop Med Hyg. 2022;108:394-402. https://doi.org/10.4269/ajtmh.22-0482
Giuliano M, Orlando S, Andreotti M, Mthiko B, Mphwere R, Kavalo T, et al. Maternal retention and early infant HIV diagnosis in a prospective cohort study of HIV-positive women and their children in Malawi. Int J STD AIDS. 2023;34:54-61. https://doi.org/10.1177/09564624221136647
John S, Lalitha G, George K, Joseph AJ. Serological response to early measles vaccination. Trop Pediatr. 2004;50:175-177. https://doi.org/10.1093/tropej/50.3.175
Leuridan E, Hens N, Hutse V, Ieven M, Aerts M, Van Damme P. Early waning of maternal measles antibodies in era of measles elimination: longitudinal study. BMJ. 2010;340:1123. https://doi.org/10.1136/bmj.c1626
Moss WJ. Measles. Lancet. 2017;390:2490-2502. https://doi.org/10.1016/S0140-6736(17)31463-0
Patel MK, Orenstein WA. Classification of global measles cases in 2013-17 as due to policy or vaccination failure: a retrospective review of global surveillance data. Lancet Glob Health. 2019;7:e313-e320. https://doi.org/10.1016/S2214-109X(18)30492-3
He Q, Fan S, Xue Z, Yuan J, Wang Y, Yang Z, et al. Waning of maternal antibody against measles virus in Shufu, China. Hum Vac Immunother. 2022;18:2045854. https://doi.org/10.1080/21645515.2022
Malshe N, Palkar S, Kulkarni R, Lalwani S, Mishra AC, Arankalle V. Early disappearance of maternal anti-measles, mumps, rubella, and varicella antibodies in Indian infants. Vaccine. 2019;37:1443-1448. https://doi.org/10.1016/j.vaccine.2019.01.043
Fisker AB, Nebie E, Schoeps A, Martins C, Rodrigues A, Zakane A, et al. A two-center randomized trial of an additional early dose of measles vaccine: effects on mortality and measles antibody levels. Clin Infect Dis. 2018;66:1573-1580. https://doi.org/10.1093/cid/cix1033
Science M, Savage R, Severini A, McLachlan E, Hughes SL, Arnold C, et al. Measles antibody levels in young infants. Pediatrics. 2019;144:e20190630. https://doi.org/10.1542/peds.2019-0630
Aaby P, Martins CL, Ravn H, Rodrigues A, Whittle HC, Benna CS. Is early measles vaccination better than later measles vaccination? Trans R Soc Trop Med Hyg. 2015;109:16-28. https://doi.org/10.1093/trstmh/tru174
Benn CS, Martins CL, Andersen A, Fisker AB, Whittle HC, Aaby P. Measles vaccination in presence of measles antibody may enhance child survival. Front Pediatr. 2020;8:20. https://doi.org/10.3389/fped.2020.00020
Nielsen S, Fisker AB, da Silva I, Byberg S, Biering-Sørensen S, Balé C, et al. Effect of early two-dose measles vaccination on childhood mortality and modification by maternal measles antibody in Guinea-Bissau, West Africa: a single-Centre open-label randomised controlled trial. EClinicalMedicine. 2022;49:101467. https://doi.org/10.1016/j.eclinm.2022.101467